Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine vs Midazolam for Pediatric Dental Premedication
NCT04509414Phase 4Completed
- Sponsor
- Peking University
- Start
- Apr 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Procedural sedation (PS), sponsored by Peking University. Primary endpoint: Venipuncture acceptance at Day 0. Started Apr 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT04509414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509414.